Clinical Trials Directory

Trials / Sponsors / IPCA Laboratories Ltd.

IPCA Laboratories Ltd.

Industry · 30 registered clinical trials.

StatusTrialPhaseStarted
CompletedBioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
Fed
Phase 12013-04-01
CompletedBioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
Fasting
Phase 12013-04-01
CompletedBioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
Fasting
Phase 12013-02-01
CompletedBioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition
Fasting
Phase 12012-12-01
CompletedBioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Fasting
Phase 12012-12-01
CompletedBioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
Fasting
Phase 12012-12-01
CompletedBioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition
Fasting
Phase 12012-11-01
CompletedBioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition
Fasting
Phase 12012-10-01
CompletedBioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions
Fed
Phase 12012-10-01
CompletedBioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition
Healthy
Phase 12012-10-01
CompletedBioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
Fasting
Phase 12012-10-01
CompletedBioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition
Fed
Phase 12012-08-01
CompletedBioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition
Fasting
Phase 12012-08-01
CompletedBioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition
Fed
Phase 12012-06-01
CompletedBioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition
Fasting
Phase 12012-06-01
CompletedBioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition
Fasting
Phase 12012-06-01
CompletedBioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
Fed
Phase 12012-05-01
CompletedBioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition
Fed
Phase 12012-05-01
CompletedBioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition
Fasting
Phase 12012-05-01
CompletedBioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition
Fed
Phase 12012-04-01
CompletedBioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition
Fasting State
Phase 12012-03-01
CompletedBioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition
Fed
Phase 12012-03-01
CompletedBioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition
Fed
Phase 12012-02-01
CompletedBioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition
Fasting State
Phase 12012-02-01
CompletedBioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
Fasting State
Phase 12011-07-01
CompletedBioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
Fed
Phase 12011-05-01
CompletedBioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition
Fasting State
Phase 12011-05-01
CompletedBioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
Fed
Phase 12011-04-01
CompletedBioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
Fasting State
Phase 12011-04-01
CompletedBioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
Fasting State
Phase 12007-11-01